Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), a Form 4 filing with the SEC showed. RA Capital bought a total of some 2.4 million shares of the company via eight transactions at an average price of approximately $2.80 apiece. Following the acquisition of additional shares, RA now owns almost 19.3 million shares of Achillion.
Disclosure: none
Recommended Reading:
Billionaire Ron Burkle Urges Morgans Hotel Group to Sell Itself…Again
Which Phone Warren Buffett Used In 2008 Could Have Changed History…But Probably Not
Ridgeback Capital Follows Steven Cohen Into Arrowhead Research
